Needleless IV connectors involve the intravenous administration of drugs and fluids to protect the central part of the vascular access systems.
SEATTLE, WASHINGTON, UNITED STATES, January 5, 2022 /EINPresswire.com/ — The Needle-less IV Connectors Market The report presents the sales and revenue of Needle-less IV Connectors by company, regions, type and application, and forecast to 2028. This report also studies the global market status, competition landscape, market share , growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter’s five forces analysis.
Click here for a sample copy @ https://www.coherentmarketinsights.com/insight/request-sample/426
Needleless IV connectors involve the intravenous administration of drugs and fluids to protect the central part of the vascular access systems. These connectors make it possible to reduce the possibilities of contamination linked to IV administration as well as to avoid IV infusions. Technologically developed needleless IV connector products such as connectors that prevent backflow of fluid, connectors with antimicrobial agents, and closed IV systems help reduce the risk of bloodstream infection associated with IV administration . Intraluminal and device cross-contamination could be avoided through the use of needleless connectors with extended residence time.
Market players are focused on developing products that reduce the risks of IV administration with traditional techniques associated with minor issues associated with the use of needleless IV connectors. This in turn is expected to propel the growth of the global needleless IV connectors market during the forecast period. For example, in 2015 and 2016, ICU Medical obtained three US patents for the MicroClave transparent needle-free connector, which ensures minimal blood backflow into the end of the catheter. In addition, RyMed Technologies announced the development of a silver coated connector, InVision-Plus in September 2014. The device is developed to reduce bacterial contamination.
𝗡𝗼𝘄 𝗔𝗻𝗱 𝗚𝗲𝘁 𝗙𝗹𝗮𝘁 𝟯𝟬% 𝗢𝗳𝗳
Direct purchase report from this company @ https://www.coherentmarketinsights.com/insight/buy-now/426
The major market players are focusing on various strategies such as acquisitions to strengthen their market presence which in turn is expected to drive the growth of the global Needle-less IV Connectors market during the forecast period. For example, ICU Medical completed the acquisition of the Hospira Infusion Systems segment of Pfizer in 2017. Additionally, in 2014, Becton, Dickinson and Company announced the acquisition of CareFusion Corporation, a medical device company that provides prevention of healthcare-related infections.
Moreover, frequent product approvals are also expected to increase the growth of the global Needle-less IV Connectors market during the forecast period. For example, in 2016 CE mark approval was granted to Hospira, which provides infusion technologies and is owned by Pfizer, for its Nuitive Clear Needle-free connector, a new needle-free intravenous IV connector. Additionally, in 2014, the US FDA approved ICU Medical Inc. for the world’s first needle-less connector, the Tego Needle-Free Connector. In 2016, Vygon SA announced the launch of Nutrifit enteral connectors, which are used to ensure safe and secure enteral nutrition.
In addition, other factors such as increasing product development, launches, as well as mergers and acquisitions, increase in chronic disease cases are also expected to fuel the growth of the global Needle-less IV Connectors market during the forecast period. For example, in 2014 B. Braun Medical Inc. entered into a distribution agreement with RyMed Technologies, LLC for the InVision-Plus neutral IV connector.
Baxter International Inc.
B. Braun Melsungen SA
Dickinson and company
Nexus Medical LLC
and Vygon SA
Request the PDF brochure of this report @ https://www.coherentmarketinsights.com/insight/request-pdf/426
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, custom research reports, and advisory services. We are known for our actionable insights and authentic reports in a variety of fields including aerospace and defense, agriculture, food and beverage, automotive, chemicals and materials, and virtually every field. and a comprehensive list of subdomains under the sun. We create value for our clients through our highly reliable and accurate reporting. We are also committed to playing a leading role in providing insight into various post-COVID-19 sectors and continue to deliver measurable and sustainable results to our clients.